EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncogenic H‐Ras Reprograms Madin‐Darby Canine Kidney (MDCK) Cell‐Derived Midbody Remnant Proteome Following Epithelial‐Mesenchymal Transition

Adnan Shafiq, Alin Rai, Rong Xu, Maoshan Chen, Wittaya Suwakulsiri, David W Greening iD, Richard J Simpson iD

PROTEOMICS · 2026

DOI: 10.1002/pmic.70051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS, 2026. Verfasst von Adnan Shafiq und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science (LIMS), School of Agriculture, Biomedicine and Environment (SABE),…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Proteome, Extracellular Vesicles, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial‐mesenchymal transition (EMT) is a fundamental, dynamic cellular process involved in embryonic development, metastasis, organ fibrosis, and tissue regeneration. To define the molecular landscape of secreted midbody remnants (MBRs) to the EMT process, a proteome analysis of MBRs released from Madin–Darby canine kidney (MDCK) cells and following oncogenic H‐Ras transformation (21D1 cells) was performed. MBRs, a new class of membranous extracellular vesicle (EV) molecularly distinct from exosomes/small EVs, were purified using sequential centrifugation/buoyant density gradient centrifugation. Proteomic profiling revealed MDCK cell‐MBRs reflect their epithelial origin (e.g., enriched CDH1, DSP, THBS1, OLCN, EPCAM proteins) and 21D1 cell‐MBRs their oncogenic and mesenchymal phenotype (e.g., HRAS, VIM, MMP14, CDH2, WNT5A, and enriched invasive and cell motility protein networks). Validation of proteome cargo revealed key protein networks associated with the EMT process in MBRs, and conserved MBR proteome across different cell types. Prominent findings were the unique expression of the immune checkpoint protein NT5E/CD73 (ecto‐5′‐nucleotidase) and ser/thr kinases LIMK1/K2 in MBRs from mesenchymal cells following their oncogenic transformation, and enrichment in Wnt signaling network proteins. These data identify the core proteome of MBRs regulated during the dynamic process of EMT and cell transformation over other EV types in context of the EMT process. Summary Epithelial‐to‐mesenchymal transition (EMT) is a critical cell biological process that occurs during embryonic development and cancer progression. Our study describes sequential purification of secreted midbody remnants (MBRs) and exosomes/sEVs from the in vitro cell line EMT model Madin–Darby canine kidney (MDCK) cells and MDCK cells transformed with oncogenic H‐Ras (21D1 cells): Proteomics identified the repertoire of enriched MDCK‐MBR proteins following EMT. MBRs display a proteome profile distinct from sEVs that is enriched with factors of the centralspindlin complex (KIF23.1, KIF4A, INCENP, CEP55, PLK1) and further includes components of the mitochondrial network, cytokinesis, microtubule movement, and intercellular connection. In the context of EMT, our data reveal enriched EMT pathways in MBRs including signaling receptor binding, regulation of cell differentiation, and Wnt, VEGF, and PDGF signaling. We have validated these findings in the context of Wnt signaling in other EV types. We identify several mesenchymal‐enriched networks in MBRs associated with focal adhesion, cell matrix, kinase activity, and cell shape/organization, while epithelial‐derived MBRs show enriched networks predominantly associated with mitochondrial (processing/transport), midbody, and plasma membrane annotation. Our study sheds light on the proteome architecture of MBRs following oncogenic H‐Ras‐induced EMT in cell transformation: collectively, our data informs ongoing efforts to delineate oncogenic drivers of cancer initiation, progression, and metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionProteomeExtracellular VesiclesProto-Oncogene Proteins p21(ras)AnimalsDogsMadin Darby Canine Kidney CellsProteomics

Stichwörter der Autor:innen

epithelial‐mesenchymal transitionextracellular vesiclesmidbody remnantsproteomics

Substanzen

ProteomeProto-Oncogene Proteins p21(ras)

Autor:innen und Institutionen

  • Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science (LIMS), School of Agriculture, Biomedicine and Environment (SABE), La Trobe University, Melbourne, Victoria, Australia.
  • Department of Cancer Biology and Department of Cell and Development Biology, Vanderbilt University Medical School, Nashville, Tennessee, USA.
  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Baker Department of Cardiovascular Research, Translation and Implementation, La Trobe University, Melbourne, Victoria, Australia.
  • Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia.
  • Nanobiotechnology Laboratory, Australia Centre For Blood Diseases, Centre Clinical School, Monash University, Melbourne, Victoria, Australia.

ORCID-Profile: David W Greening, Richard J Simpson

Zitieren

APA

Shafiq, A., Rai, A., Xu, R., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2026). Oncogenic H‐Ras Reprograms Madin‐Darby Canine Kidney (MDCK) Cell‐Derived Midbody Remnant Proteome Following Epithelial‐Mesenchymal Transition. PROTEOMICS. https://doi.org/10.1002/pmic.70051

Vancouver

Shafiq A, Rai A, Xu R, Chen M, Suwakulsiri W, Greening DW, et al. Oncogenic H‐Ras Reprograms Madin‐Darby Canine Kidney (MDCK) Cell‐Derived Midbody Remnant Proteome Following Epithelial‐Mesenchymal Transition. PROTEOMICS. 2026. doi:10.1002/pmic.70051

BibTeX
@article{Shafiq2026,
  author = {Shafiq, Adnan and Rai, Alin and Xu, Rong and Chen, Maoshan and Suwakulsiri, Wittaya and Greening, David W and Simpson, Richard J},
  title = {Oncogenic H‐Ras Reprograms Madin‐Darby Canine Kidney (MDCK) Cell‐Derived Midbody Remnant Proteome Following Epithelial‐Mesenchymal Transition},
  journal = {PROTEOMICS},
  year = {2026},
  doi = {10.1002/pmic.70051}
}
Kostenlos starten →